Literature DB >> 3624800

Reduced serum thyroglobulin response to bovine TSH in malignant hypofunctioning solid thyroid nodules: comparison to benign nodular disease.

Z Leite, P Carneiro, A Halpern, G Medeiros-Neto.   

Abstract

Forty-three euthyroid patients with a single, solid, nonfunctioning thyroid nodule were submitted to fine needle aspiration biopsy and serum thyroglobulin (Tg) was measured before and after (48h) 10 U of bovine TSH. Twenty-two normal subjects were also submitted to the bTSH test. Patients with nonfunctioning nodules were divided in two groups: (I) Benign or Suspicious Cytology (n = 32), (II) Malignant tissue (n = 11). In the latter group all patients underwent surgery and the pathology findings confirmed the presence of thyroid carcinoma. Twenty-one patients with benign or suspicious cytology were also operated upon and the diagnosis was colloid goiter (n = 16) and follicular adenoma (n = 5). In eleven other patients the nodule reduced significantly in size (8) or was no longer palpable after suppressive therapy (3). Normal individuals had a basal serum Tg mean +/- SD value of 12 +/- 7.2 ng/ml and a peak Tg value of 44 +/- 47 ng/ml. Serum Tg values were significantly higher (p less than 0.01) in patients with benign and malignant nodules. However the mean absolute increment (delta Tg) after bTSH was significantly lower (p less than 0.01) in patients with malignant nodules (7.2 +/- 4.8 ng/ml) as compared with normal subjects (22 +/- 16 ng/ml) or subjects with benign nodules (31 +/- 30 ng/ml). The relative (%) serum Tg increment was also significantly lower in patients with malignant tissues (14 +/- 11) as compared to those with benign nodules (77 +/- 86) or normal subjects (247 +/- 173).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3624800     DOI: 10.1007/BF03348125

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  15 in total

Review 1.  Nodular thyroid disease. Evaluation and management.

Authors:  M T Rojeski; H Gharib
Journal:  N Engl J Med       Date:  1985-08-15       Impact factor: 91.245

Review 2.  Management of thyroid nodules. II: Scanning techniques, thyroid suppressive therapy, and fine needle aspiration.

Authors:  M W Ashcraft; A J Van Herle
Journal:  Head Neck Surg       Date:  1981 Mar-Apr

3.  Thyroidal response to graded doses of bovine thyrotropin.

Authors:  R P Uller; A J van Herle; I J Chopra
Journal:  J Clin Endocrinol Metab       Date:  1977-08       Impact factor: 5.958

4.  Malignant follicles of a differentiated thyroid carcinoma releasing iodinated thyroglobulin into the lymphatic vessels.

Authors:  F Gebel; H Studer
Journal:  Clin Endocrinol (Oxf)       Date:  1984-04       Impact factor: 3.478

5.  The effect of elevated doses of thyrotropin on mouse thyroid.

Authors:  M Gafni; J Gross
Journal:  Endocrinology       Date:  1975-12       Impact factor: 4.736

6.  Elevated serum thyroglobulin. A marker of metastases in differentiated thyroid carcinomas.

Authors:  A J Herle; R P Uller
Journal:  J Clin Invest       Date:  1975-08       Impact factor: 14.808

7.  Serum thyroglobulin in differentiated thyroid carcinoma.

Authors:  U B Ericsson; L Tegler; S Lennquist; S B Christensen; E Ståhl; J I Thorell
Journal:  Acta Chir Scand       Date:  1984

8.  Fine-needle aspiration biopsy of the thyroid. The problem of suspicious cytologic findings.

Authors:  H Gharib; J R Goellner; A R Zinsmeister; C S Grant; J A Van Heerden
Journal:  Ann Intern Med       Date:  1984-07       Impact factor: 25.391

9.  The influence of percutaneous fine needle aspiration on serum thyroglobulin.

Authors:  E G Lever; S Refetoff; N H Scherberg; K Carr
Journal:  J Clin Endocrinol Metab       Date:  1983-01       Impact factor: 5.958

Review 10.  Management of thyroid nodules. I: History and physical examination, blood tests, X-ray tests, and ultrasonography.

Authors:  M W Ashcraft; A J Van Herle
Journal:  Head Neck Surg       Date:  1981 Jan-Feb
View more
  1 in total

1.  Congenital hypothyroid goiter with deficient thyroglobulin. Identification of an endoplasmic reticulum storage disease with induction of molecular chaperones.

Authors:  G Medeiros-Neto; P S Kim; S E Yoo; J Vono; H M Targovnik; R Camargo; S A Hossain; P Arvan
Journal:  J Clin Invest       Date:  1996-12-15       Impact factor: 14.808

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.